IP Library Granted Patent US 9,574,169
Granted Patent B2
US 9,574,169 · App. 13/264,395 · Granted Feb 21, 2017

Cryoprotectants for freeze drying of lactic acid bacteria

Inventors: Sam Corveleyn (Zwijnaarde, BE); Patrick Dhaese (Zwijnaarde, BE); Sabine Neirynck (Zwinjaarde, BE); Lothar Steidler (Zwijnaarde, BE)
Assignee: INTREXON ACTOBIOTICS NV
C12N1/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,574,169
App. No.
13/264,395
Granted
Feb 21, 2017
Kind
B2
Abstract

The present invention comprises the discovery and development of an effective cryoprotectant composition, without containing skim milk or any other animal-derived compounds, to achieve long-term stability of freeze-dried lactic acid bacteria (LAB), at different temperatures, whereby the retention of viability of the freeze-dried LAB after 6 months of storage, preferably after 9 months of storage, more preferably after 12 months of storage is more than 50%. The invention is in the field of producing freeze dried bacteria, in particular Lactic acid bacteria. More in particular, the invention relates to the use of a novel combination of cryoprotectants for increasing the viability of bacteria after freeze drying, improving the texture of the lyofilized cake for easy grinding and improving the long term stability of the freeze dried bacteria at different temperature conditions. The invention further relates to such freeze dried bacteria for use in food industry or in human or animal health applications. More in particular, the invention relates to the increased viability and long-term storage of recombinant bacteria capable of expressing heterologous proteins or peptides and administered to humans or animals for therapeutic or vaccination purposes.

Claims (40)

1. A freeze dried composition comprising:

(a) a freeze dried Lactococcus lactis bacterium; and

(b) stabilizing compounds consisting of:

(1) a starch hydrolysate, wherein the starch hydrolysate is selected from dextran and dextrin,

(2) a glutamic acid salt, and

(3) a polyol, wherein the polyol is selected from sorbitol and mannitol, and wherein the composition is free of milk.

2. The freeze dried composition according to claim 1 , wherein prior to freeze drying:

the amount of starch hydrolysate ranges from about 2.0% to about 10% (w/v);

the amount of glutamic acid salt ranges from about 2.0% to about 10% (w/v); and

the amount of polyol ranges from about 5.0 to about 30% (w/v).

3. The freeze dried composition according to claim 1 , wherein the glutamic acid salt is sodium glutamate.

4. The freeze dried composition according to claim 1 , wherein the starch hydrolysate is dextran.

5. A method for freeze drying Lactococcus lactis bacteria comprising:

(a) providing a bacterial biomass comprising Lactococcus lactis bacteria;

(b) mixing the biomass with a combination of stabilizing compounds to form a composition, wherein the combination of stabilizing compounds consists of:

(1) a starch hydrolysate, wherein the starch hydrolysate is selected from dextran and dextrin,

(2) a glutamic acid salt, and

(3) a polyol, wherein the polyol is selected from sorbitol and mannitol; and

(c) freeze drying the composition,

wherein the biomass is free of milk.

6. The freeze dried composition according to claim 1 , wherein the Lactococcus lactis bacterium comprises one or more recombinant nucleic acids which are heterologous to the Lactococcus lactis bacterium.

7. A culture or starter culture composition comprising the freeze dried composition according to claim 1 .

8. A medicament comprising the freeze dried composition according to claim 1 .

9. A food ingredient comprising the freeze dried composition according to claim 1 .

10. A food product or animal feed comprising the culture or starter culture composition according to claim 7 .

11. A freeze dried composition comprising:

(a) a freeze dried Lactococcus lactis bacterium; and

(b) stabilizing compounds consisting of:

(1) a starch hydrolysate selected from dextran and dextrin, wherein the amount of the starch hydrolysate ranges from about 5% to about 10% (w/v);

(2) sodium glutamate, wherein the amount of the sodium glutamate ranges from about 5.0% to about 10% (w/v); and

(3) a polyol selected from sorbitol and mannitol, wherein the amount of the polyol ranges from about 10% to about 20% (w/v),

wherein the composition is free of milk.

12. The freeze dried composition according to claim 11 , wherein the starch hydrolysate is dextrin and the polyol is sorbitol.

13. The freeze dried composition according to claim 12 , wherein the freeze dried composition is free of animal-derived compounds.

14. The freeze dried composition according to claim 1 , wherein the Lactococcus lactis bacterium was cultured from a medium lacking milk.

15. The freeze dried composition according to claim 1 , wherein the composition is free of animal-derived compounds.

16. The freeze dried composition according to claim 1 , wherein the Lactococcus lactis bacterium in the composition retains at least 50% viability after 12 months when stored at −20° C. or 5° C.

17. The freeze dried composition according to claim 1 , wherein the Lactococcus lactis bacterium in the composition retains at least 80% viability after 12 months when stored at −20° C. or 5° C.

18. The freeze dried composition according to claim 1 , wherein the starch hydrolysate is dextrin and the polyol is sorbitol.

19. The freeze dried composition according to claim 1 , wherein the Lactococcus lactis bacterium is genetically modified.

Assignments (2)
CHANGE OF NAME Recorded Jan 28, 2016
From: ACTOGENIX NV
To: INTREXON ACTOBIOTICS NV
Reel/Frame 037627/0463 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2011
From: CORVELEYN, SAM; DHAESE, PATRICK; NEIRYNCK, SABINE; STEIDLER, LOTHAR
To: ACTOGENIX NV
Reel/Frame 027075/0997 →
Priority Claims (1)
EP 09100265 · Apr 30, 2009 · regional
Continuity (1)
Related Publication 20120039853A1 · Feb 16, 2012